Acute ACAT1/SOAT1 Blockade Increases MAM Cholesterol and Strengthens ER-Mitochondria Connectivity
International Journal of Molecular Sciences · 14.03.2023 · 24 (6) · 5525
DOI: 10.3390/ijms24065525 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.03.2023. Verfasst von Taylor C Harned und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Cell Biology, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cholesterol. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Cholesterol is a key component of all mammalian cell membranes. Disruptions in cholesterol metabolism have been observed in the context of various diseases, including neurodegenerative disorders such as Alzheimer’s disease (AD). The genetic and pharmacological blockade of acyl-CoA:cholesterol acyltransferase 1/sterol O-acyltransferase 1 (ACAT1/SOAT1), a cholesterol storage enzyme found on the endoplasmic reticulum (ER) and enriched at the mitochondria-associated ER membrane (MAM), has been shown to reduce amyloid pathology and rescue cognitive deficits in mouse models of AD. Additionally, blocking ACAT1/SOAT1 activity stimulates autophagy and lysosomal biogenesis; however, the exact molecular connection between the ACAT1/SOAT1 blockade and these observed benefits remain unknown. Here, using biochemical fractionation techniques, we observe cholesterol accumulation at the MAM which leads to ACAT1/SOAT1 enrichment in this domain. MAM proteomics data suggests that ACAT1/SOAT1 inhibition strengthens the ER-mitochondria connection. Confocal and electron microscopy confirms that ACAT1/SOAT1 inhibition increases the number of ER-mitochondria contact sites and strengthens this connection by shortening the distance between these two organelles. This work demonstrates how directly manipulating local cholesterol levels at the MAM can alter inter-organellar contact sites and suggests that cholesterol buildup at the MAM is the impetus behind the therapeutic benefits of ACAT1/SOAT1 inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Cell Biology, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.
- Chinese Academy of Sciences, Beijing 100045, China.
- Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
ORCID-Profile: Radu V Stan, Rajarshi Chakrabarti
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- NIA NIH HHS
- NIH HHS
- NIH
- Dartmouth bioMT core NIH/NIHMS COBRE
- Dartmouth Cancer Center Core NIH
Zitieren
APA
Harned, T. C., Stan, R. V., Cao, Z., Chakrabarti, R., Higgs, H. N., Chang, C. C. Y., & Chang, T. Y. (2023). Acute ACAT1/SOAT1 Blockade Increases MAM Cholesterol and Strengthens ER-Mitochondria Connectivity. International Journal of Molecular Sciences, 24(6), 5525. https://doi.org/10.3390/ijms24065525
Vancouver
Harned TC, Stan RV, Cao Z, Chakrabarti R, Higgs HN, Chang CCY, et al. Acute ACAT1/SOAT1 Blockade Increases MAM Cholesterol and Strengthens ER-Mitochondria Connectivity. International Journal of Molecular Sciences. 2023;24(6):5525. doi:10.3390/ijms24065525
BibTeX
@article{Harned2023,
author = {Harned, Taylor C and Stan, Radu V and Cao, Ze and Chakrabarti, Rajarshi and Higgs, Henry N and Chang, Catherine C Y and Chang, Ta Yuan},
title = {Acute ACAT1/SOAT1 Blockade Increases MAM Cholesterol and Strengthens ER-Mitochondria Connectivity},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {6},
pages = {5525},
doi = {10.3390/ijms24065525}
}
EUVIMED